Digital Health Series A Investors & VC Firms
1014 firms in this list, with a median first check of $500K. 301 of them lead rounds. Generated from verified public data and updated continuously.
Cure Kids Ventures
AucklandSeed–Series A
6 people
Red Bear Angels
IthacaSeed–Series A$100K – $1M
3 people
New Leaf Venture Partners
New YorkSeed–Series B
7 people
500 Startups Vietnam
Palo AltoPre-Seed–Series A
10 people
CLI Ventures
Palo AltoSeed–Late Stage
6 people
Claremont Creek Ventures
OaklandSeed–Late Stage$500K – $3M
5 people
Incite.org
San FranciscoPre-Seed–Series A
5 people
Med-Fine Capital
ShanghaiSeed–Series A
8 people
BCF Ventures
MontrealSeed–Series B
7 people
Future Positive Capital
Pre-Seed–Series A
4 people
Shoni Health Ventures
Ramat GanSeed–Growth
10 people
Averin Capital
New YorkSeed–Growth
9 people
Chakra Growth Fund
Pre-Seed–Growth
6 people
20/20 HealthCare Partners LLC
AuburndaleSeed–Series A
7 people
Wildwood Ventures
BoulderPre-Seed–Series A
7 people
DEFTA Partners
San FranciscoSeed–Series A
5 people
Vertex Ventures HC
SingaporeSeed–Growth$500K – $10M
4 people
Recode Ventures
San FranciscoSeed–Series A
8 people
Relia Health
OntarioPre-Seed–Series A
5 people
SV Latam Capital
San FranciscoSeed–Series A$50K – $500K
2 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Lang Sheng Investment Group Co. Ltd.
ShanghaiPre-Seed–Series A
7 people
Chile Ventures
SantiagoSeed–Series A$50K – $1M
2 people
Consorcio Ventures
SantiagoSeed–Series A$500K – $2.5M
6 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)Series A Investors & VC Firms in Global (2210)
Data sourced from public filings and firms' own websites — see our methodology.






















































































